Lab Tests
Nonspecific testing
- CBC – neutrophilic leukocytosis most common abnormality
- C-reactive protein (CRP)
- Preferred test to detect inflammatory processes (Choosing Wisely: 20 Things Physicians and Patients Should Question, 2017; American Society for Clinical Pathology)logy)
- Frequently elevated
- If CRP not available, order erythrocyte sedimentation rate (ESR)
- IgE – usually normal
Serum precipitating antibodies – testing based on suspected exposure
- Positive findings are only suggestive and help document patient exposure to antigen
- Low titers do not exclude disease
- Enzyme-linked immunosorbent assay (ELISA) more sensitive than immunodiffusion
Other Tests
Pulmonary function studies
- Restrictive or mixed obstructive and restrictive patterns with decrease in diffusing capacity of lung for carbon monoxide (DLCO) usually <80% – normal results do not exclude disease
- No discriminatory power to differentiate HP from other interstitial lung diseases
Arterial blood gases
- demonstrate hypoxemia only with exercise in acute and subacute disease
Invasive testing – BAL using bronchoscopy
- Lymphocytosis
- Usual presentation is ≥30% in nonsmokers and ≥20% in smokers
- CD3+/CD8+/CD56+/CD57+/CD10-
- CD4+/CD8+
- Usually <1 in acute disease but may be >1 in chronic disease
- May help differentiate HP from sarcoidosis, where ratio is usually >1
- Eosinophilia common (75%) in advanced disease
Hypersensitivity Pneumonitis I
Method: Qualitative Immunodiffusion
Recommended Use
Evaluate patients suspected of having hypersensitivity pneumonitis induced by exposure to Aspergillus fumigatus,
Thermoactinomyces vulgaris, Aureobasidium pullulans, or Micropolyspora faeni
Hypersensitivity Pneumonitis 2
Method: Qualitative Immunodiffusion
Recommended Use
Evaluate patients suspected of having hypersensitivity pneumonitis induced by exposure to Aspergillus fumigatus,
Thermoactinomyces vulgaris, Aureobasidium pullulans, or Micropolyspora faeni
Hypersensitivity Pneumonitis Panel
Method: Qualitative Immunodiffusion
Recommended Use
Evaluate patients suspected of having hypersensitivity pneumonitis induced by exposure to Aspergillus fumigatus,
Thermoactinomyces vulgaris, Aurebasidium pullulans, Micropolyspora faeni, Aspergillus flavus, Saccharomonospora viridis, or Thermoactinomyces candidus
Lymphocyte Subset Panel 4 – T-Cell Subsets Percent and Ratio, Bronchoalveolar Lavage
Method: Flow Cytometry
Recommended Use
Support the diagnosis of sarcoidosis
Hypersensitivity Pneumonitis Extended Panel (Farmer’s Lung Panel)
Method: Qualitative Immunodiffusion/Quantitative ImmunoCAP Fluorescent Enzyme Immunoassay
Recommended Use
Panel includes allergen and antibody testing from hypersensitivity pneumonitis panels as well as allergen testing, Phoma betae, food, beef, pork, epidermals, and animal proteins and feathers
References
Guidelines
- Richerson HB, Bernstein IL, Fink JN, Hunninghake GW, Novey HS, Reed CE, Salvaggio JE, Schuyler MR, Schwartz HJ, Stechschulte DJ. Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol. 1989; 84(5 Pt 2): 839-44. PubMed
- Choosing Wisely. An initiative of the ABIM Foundation. [Accessed: Apr 2019]
- Miller R, Allen TC, Barrios RJ, Beasley MB, Burke L, Cagle PT, Capelozzi VL, Ge Y, Hariri LP, Kerr KM, Khoor A, Larsen BT, Mark EJ, Matsubara O, Mehrad M, Mino-Kenudson M, Raparia K, Roden AC, Russell P, Schneider F, Sholl LM, Smith ML. Hypersensitivity pneumonitis: a perspective from members of the Pulmonary Pathology Society. Arch Pathol Lab Med. 2017; PubMed